Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian h5n1 influenza virus

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Wei, C. J.
  • Xu, L.
  • Kong, W. P.
  • Shi, W.
  • Canis, K.
  • Stevens, J.
  • Yang, Z. Y.
  • Dell, A.
  • Haslam, S. M.
  • Wilson, Ian
  • Nabel, G. J.

publication date

  • July 2008

journal

  • Journal of Virology  Journal

abstract

  • Although the human transmission of avian H5N1 virus remains low, the prevalence of this highly pathogenic infection in avian species underscores the need for a preventive vaccine that can be made without eggs. Here, we systematically analyze various forms of recombinant hemagglutinin (HA) protein for their potential efficacy as vaccines. Monomeric, trimeric, and oligomeric H5N1 HA proteins were expressed and purified from either insect or mammalian cells. The immunogenicity of different recombinant HA proteins was evaluated by measuring the neutralizing antibody response. Neutralizing antibodies to H5N1 HA were readily generated in mice immunized with the recombinant HA proteins, but they varied in potency depending on their multimeric nature and cell source. Among the HA proteins, a high-molecular-weight oligomer elicited the strongest antibody response, followed by the trimer; the monomer showed minimal efficacy. The coexpression of another viral surface protein, neuraminidase, did not affect the immunogenicity of the HA oligomer, as expected from the immunogenicity of trimers produced from insect cells. As anticipated, HA expressed in mammalian cells without NA retained the terminal sialic acid residues and failed to bind alpha2,3-linked sialic acid receptors. Taken together, these results suggest that recombinant HA proteins as individual or oligomeric trimers can elicit potent neutralizing antibody responses to avian H5N1 influenza viruses.

subject areas

  • Amino Acid Sequence
  • Animals
  • Antibodies, Viral
  • DNA Primers
  • Enzyme-Linked Immunosorbent Assay
  • Genetic Vectors
  • Hemagglutinin Glycoproteins, Influenza Virus
  • Influenza A Virus, H5N1 Subtype
  • Influenza Vaccines
  • Mice
  • Molecular Sequence Data
  • Recombinant Proteins
scroll to property group menus

Identity

PubMed Central ID

  • PMC2447076

International Standard Serial Number (ISSN)

  • 0022-538X

Digital Object Identifier (DOI)

  • 10.1128/jvi.00187-08

PubMed ID

  • 18417563
scroll to property group menus

Additional Document Info

start page

  • 6200

end page

  • 6208

volume

  • 82

issue

  • 13

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support